← Back to VTS Methodology
VTS Scoring Log

Ascension Peptides

US-facing gray market· Lyophilized vials· Scored July 2026· ascensionpeptides.com →

Ascension Peptides earns Moderate Transparency on the basis of strong traceability infrastructure - COAs are searchable by lot number, batch, and date through a public database, and the issuing lab (MZ Biolabs, Tucson AZ, DEA-registered) is named with the analyst identified on each result. Founded in 2024, the operation is relatively new but its documentation practices are among the most structured in the catalog. The score is held down primarily by a strict no-refund policy that scores at the bottom of the Policy Transparency dimension.

76 /100
Moderate Transparency
Strong on the testing core: named independent lab (MZ Biolabs, Tucson AZ, DEA-registered), analyst-identified COAs, and a searchable COA database by batch, lot, date, and cap color. Founded 2024 - new operation with strong documentation infrastructure from the outset. Held from High Transparency primarily by a strict no-refund policy that disadvantages buyers and an operational track record too short to fully assess.
Dimension Scores
DimensionMaxNotesScore
Third-Party Testing Practice30Named independent lab: MZ Biolabs, Tucson, Arizona, holding DEA Schedule III registration. HPLC purity and mass spectrometry identity confirmed. Analyst Ken Pendarvis named on COAs, adding an additional layer of accountability. Per-batch testing for the catalog. Naming the specific lab and analyst is a genuine differentiator from most competitors who describe testing generically without identification.24/30
Batch Traceability & Verification20Searchable COA database at a dedicated URL, filterable by product name, SKU, batch/lot number, cap color, purity, and date. A buyer can input the lot number from a received vial and retrieve the matching COA. This is among the strongest lot-traceability implementations observed in this market, approaching the QR-to-lab gold standard without the QR code mechanism.17/20
COA Accessibility15COA database publicly accessible before purchase. Approximately 75 records at time of scoring (per independent review), searchable and previewable online. No login required to access. Open public database is the highest accessibility tier.13/15
COA Completeness15HPLC purity and mass spectrometry identity confirmed. Named analyst on COAs. COA format includes batch-specific data. Sterility and endotoxin not confirmed in public testing protocol description. Full COA completeness assessment limited by what is publicly described vs. what the actual COA document shows; partial credit reflecting confirmed methods.11/15
Testing Recency10COA database is searchable by date, allowing assessment of how recently any given product was tested. Active operation with ongoing testing. Founded 2024, so the archive is short but fully dated.8/10
Policy Transparency5Significant deduction here. The terms of use include a no-refund policy for most situations. Replacement for damaged or incorrect orders described in FAQ, but the baseline is no-refund rather than the 14-day return window or quality-guarantee framework that higher-scoring vendors offer. The policy also includes a no-refund for customs seizure. For a buyer in a gray market, a restrictive no-refund default is a meaningful transparency gap on the policy dimension.1/5
Operational Track Record5Founded 2024. Colorado-based with published address (Kansas City mailing address) and phone number. Two addresses in public record, which independent reviewers have noted without resolution. Operation is new - the strong COA infrastructure is a positive signal for a 2024 launch, but multi-year track record is not yet established.2/5
Total76/100
Community Signal
Independent Test Results
No community-commissioned independent blind-buy testing results identified in public community archives as of July 2026. Ascension Peptides is relatively new (2024) and independent community testing coverage is limited accordingly.
Community Experience
Ascension Peptides carries a Trustpilot rating of approximately 4.8/5 across 88+ reviews as of early 2026, with specific praise for service responsiveness. Community mentions are largely positive on documentation quality. The no-refund policy has been flagged in some community discussions as a concern.
Scoring Notes
The named lab is the genuine differentiator
Naming MZ Biolabs specifically, with DEA registration verifiable independently and an analyst named on COAs, is a level of accountability that most vendors in this market do not match. A buyer can confirm the lab exists and holds the stated credentials before purchasing. That is a meaningful transparency signal that earned the strong testing practice and accessibility scores.
The refund policy is the meaningful drag
The no-refund default is the single largest gap between Ascension's documentation quality and a High Transparency band. Strong COA infrastructure combined with a restrictive refund policy creates a trust asymmetry: the vendor can prove quality; the buyer has limited recourse if something goes wrong. The policy dimension exists specifically to measure this asymmetry.